Scil Proteins Appoints Advisory Board
Scil Proteins announced that it has completed the formation of its advisory board (AB). The AB is comprised of Dr. Andreas Menrad, Dr. Jürgen Wahl and Rainer Kroell.
Andreas Menrad, PhD, is currently the Vice President of Antibody Therapeutics at Genzyme’s European Research site in Cambridge, UK. Prior to this, he was Genzyme’s Director of Research and Development. Dr. Menrad has extensive experience in the fields of experimental dermatology, inflammation and oncology as well as antibody engineering, having held positions as Project Team Leader and Director of Antibody Engineering and Anti-Angiogenesis Research at Schering AG. Dr. Menrad graduated from the University of Stuttgart and conducted his PhD at the Max-Planck Institute. In addition, he was a post-doctoral fellow at the Wistar Institute in Philadelphia, Pennsylvania.
Jürgen Wahl, PhD, is the former head of biotech production at Roche in Penzberg, Germany. In his 22 years at Roche, Dr. Wahl’s activities focused on the fermentation of microorganisms for enzyme production and setting up the mammalian cell culture unit for Epoetin beta, as well as diagnostic and therapeutic antibodies. As Head of Biotech Production, he was also responsible for the development and production of various therapeutic drug substances. Dr. Wahl earned degrees in biochemistry, biology and pharmacy from the University of Tübingen.
Dr. Menrad will be responsible for advising the Pharma business unit of Scil Proteins, focusing on the Affilin® technology and Affilin® product development, while Dr. Wahl will advise the recombinant protein production business unit, focusing on process development and GMP manufacturing.
Rainer Kroell holds a diploma in business studies from the University of Passau and gained his specific qualification as tax advisor in 1997 and his certification as an auditor in 2000. In 1999, he co-founded GKK Partners and is now Senior Partner of this recognized and well-known company for tax consultation and auditing in Munich, Germany. Mr. Kroell has also a focus on biotechnology and he supports Scil Proteins in various financial and taxation issues.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Last viewed contents
Agilent aigns agreement to acquire assets from Young In Scientific Co. Ltd.

With “Swarming AI” Against COVID and Other Diseases - Network of German research institutions uses pioneering artificial intelligence technology to analyze distributed data

Provocative prions may protect yeast cells from stress
Category:Hoffmann-La_Roche
Thoracic_cage
Biogen Idec and Swedish Orphan Biovitrum Decide to Advance Long-Lasting Hemophilia A Therapy into a Registrational Trial
Experimental_cancer_treatment
Category:Medical_literature
Lonza Acquires Biotech Service Provider Algonomics - Lonza integrates Innovative Technology in its Protein Design Services offering
Eavesdropping on bacterial conversations may improve chronic wound healing

QX600 Droplet Digital PCR System | Droplet Digital PCR systems | Bio-Rad Laboratories
